The FDA NDA submission will be informed by and follow the FDA pre submission meeting. NDA approvals could take up to 9 or 10 months. What I have seen in some other Biotechs is an appreciation to the share price as a company gets closer to the approval date. If that is coupled with partnership or licensing agreements providing commercial validation then the uplift to the share price is even greater. LTP is well
positioned on these fronts.
Ann: SPONTAN achieves positive clinical study results, page-75
-
- There are more pages in this discussion • 111 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LTP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
73.0¢ |
Change
-0.065(8.18%) |
Mkt cap ! $61.89M | |||
| Open | High | Low | Value | Volume |
| 79.5¢ | 79.5¢ | 72.0¢ | $746.8K | 995.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9000 | 72.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 73.0¢ | 7651 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| LTP (ASX) Chart |